Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuron ; 58(2): 195-209, 2008 Apr 24.
Article in English | MEDLINE | ID: mdl-18439405

ABSTRACT

In a forward genetic screen for mutations that destabilize the neuromuscular junction, we identified a novel long isoform of Drosophila ankyrin2 (ank2-L). We demonstrate that loss of presynaptic Ank2-L not only causes synapse disassembly and retraction but also disrupts neuronal excitability and NMJ morphology. We provide genetic evidence that ank2-L is necessary to generate the membrane constrictions that normally separate individual synaptic boutons and is necessary to achieve the normal spacing of subsynaptic protein domains, including the normal organization of synaptic cell adhesion molecules. Mechanistically, synapse organization is correlated with a lattice-like organization of Ank2-L, visualized using extended high-resolution structured-illumination microscopy. The stabilizing functions of Ank2-L can be mapped to the extended C-terminal domain that we demonstrate can directly bind and organize synaptic microtubules. We propose that a presynaptic Ank2-L lattice links synaptic membrane proteins and spectrin to the underlying microtubule cytoskeleton to organize and stabilize the presynaptic terminal.


Subject(s)
Ankyrins/genetics , Drosophila Proteins/genetics , Microtubules/metabolism , Neuromuscular Junction/physiology , Presynaptic Terminals/metabolism , Amino Acid Motifs/physiology , Animals , Animals, Genetically Modified , Cell Adhesion Molecules, Neuronal/metabolism , Drosophila , Gene Expression Regulation/genetics , Horseradish Peroxidase/metabolism , Larva , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microscopy, Electron, Transmission/methods , Mutation/genetics , Neuromuscular Junction/ultrastructure , Presynaptic Terminals/ultrastructure , Synapsins/metabolism , Synaptic Transmission/genetics
2.
Proc Natl Acad Sci U S A ; 104(22): 9296-300, 2007 May 29.
Article in English | MEDLINE | ID: mdl-17517645

ABSTRACT

Like blood neutrophils, dHL60 cells respond to a uniform concentration of attractant by polarizing in apparently random directions. How each cell chooses its own direction is unknown. We now find that an arrow drawn from the center of the nucleus of an unpolarized cell to its centrosome strongly predicts the subsequent direction of attractant-induced polarity: Of 60 cells that polarized in response to uniform f-Met-Leu-Phe (fMLP), 42 polarized to the left of this arrow, 6 polarized to the right, and 12 polarized directly toward or away from the centrosome. To investigate this directional bias we perturbed a regulatory pathway, downstream of Cdc42 and partitioning-defective 6 (Par6), which controls centrosome orientation relative to polarity of other cells. Dominant negative Par6 mutants block polarity altogether, as previously shown for disrupting Cdc42 activity. Cells remain able to polarize, but without directional bias, if their microtubules are disrupted with nocodazole, or they express mutant proteins that interfere with activities of PKCzeta or dynein. Expressing constitutively active glycogen synthase kinase 3beta (GSK3beta) causes cells to polarize preferentially to the right. Distributions of most of these polarity regulators localize to the centrosome but show no left-right asymmetry before polarization. Together, these findings suggest that an intrinsically chiral structure, perhaps the centrosome, serves as a template for directing polarity in the absence of spatial cues. Such a template could help to determine left-right asymmetry and planar polarity in development.


Subject(s)
Cell Polarity , Cell Line, Tumor , Cell Polarity/drug effects , Centrosome/metabolism , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Humans , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Protein Binding , Signal Transduction , cdc42 GTP-Binding Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL